Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Edwards

Showing results (131-140 of 196) with videos related to

Pageof 20
Sort By:
Arthritis Research & Therapy|May 12, 2019
Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysisArthur Kavanaugh, Dafna D Gladman, Christopher J Edwards, et al.
Rheumatology (Oxford, England)|December 1, 2009
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature reviewSarah L Westlake, Alexandra N Colebatch, Janis Baird, et al.
Rheumatology (Oxford, England)|July 6, 2012
Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohortFelix Chua, Alexandra M Higton, Alexandra N Colebatch, et al.
Clinical Epidemiology|June 27, 2018
The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort studyEdward Burn, Christopher J Edwards, David W Murray, et al.
Rheumatology (Oxford, England)|June 8, 2021
Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patientsAlvin F Wells, Christopher J Edwards, Alan J Kivitz, et al.
Regional Anesthesia and Pain Medicine|October 2, 2020
Ilioinguinal/Iliohypogastric versus quadratus lumborum nerve blockade for elective open inguinal herniorrhaphy: a prospective, randomized, double-blinded, equivalency trialChristopher J Edwards, Robert S Weller, James D Turner, et al.
Seminars in Arthritis and Rheumatism|October 23, 2017
Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysisSamuel Hawley, René Cordtz, Lene Dreyer, et al.
Rheumatology (Oxford, England)|November 13, 2010
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature reviewSarah L Westlake, Alexandra N Colebatch, Janis Baird, et al.
Annals of the Rheumatic Diseases|January 22, 2016
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)Christopher J Edwards, Francisco J Blanco, Jeffrey Crowley, et al.
Rheumatology (Oxford, England)|January 17, 2019
Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry dataSamuel Hawley, M Sanni Ali, René Cordtz, et al.
Pageof 20

Showing results (131-140 of 196) with videos related to

Sort By:
Pageof 20
Arthritis Research & Therapy|May 12, 2019
Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysisArthur Kavanaugh, Dafna D Gladman, Christopher J Edwards, et al.
Rheumatology (Oxford, England)|December 1, 2009
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature reviewSarah L Westlake, Alexandra N Colebatch, Janis Baird, et al.
Rheumatology (Oxford, England)|July 6, 2012
Idiopathic inflammatory myositis-associated interstitial lung disease: ethnicity differences and lung function trends in a British cohortFelix Chua, Alexandra M Higton, Alexandra N Colebatch, et al.
Clinical Epidemiology|June 27, 2018
The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort studyEdward Burn, Christopher J Edwards, David W Murray, et al.
Rheumatology (Oxford, England)|June 8, 2021
Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patientsAlvin F Wells, Christopher J Edwards, Alan J Kivitz, et al.
Regional Anesthesia and Pain Medicine|October 2, 2020
Ilioinguinal/Iliohypogastric versus quadratus lumborum nerve blockade for elective open inguinal herniorrhaphy: a prospective, randomized, double-blinded, equivalency trialChristopher J Edwards, Robert S Weller, James D Turner, et al.
Seminars in Arthritis and Rheumatism|October 23, 2017
Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysisSamuel Hawley, René Cordtz, Lene Dreyer, et al.
Rheumatology (Oxford, England)|November 13, 2010
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature reviewSarah L Westlake, Alexandra N Colebatch, Janis Baird, et al.
Annals of the Rheumatic Diseases|January 22, 2016
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)Christopher J Edwards, Francisco J Blanco, Jeffrey Crowley, et al.
Rheumatology (Oxford, England)|January 17, 2019
Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry dataSamuel Hawley, M Sanni Ali, René Cordtz, et al.
Pageof 20